There is a magical moment in the pharmaceutical industry when a government approves a new treatment. For companies researching psilocybin, the psychoactive component in psychedelic mushrooms, that moment is now.

Six years after its first adult-use cannabis sale, Colorado set a monthly sales record in June totaling $158,102,628, according to state Department of Revenue Marijuana Enforcement Division Revenue outlined by the Denver Post. Last June, cannabis sales in the state reached about $122.4 million.

With the COVID-19 pandemic continuing to rage around the world, many are left wondering what, if any, is cannabis’ role in ameliorating the spread or possibly treating patients affected by the virus?

Four more Ohio cities will be voting on local measures to decriminalize marijuana this November, activists say.